Gilead Sciences, Inc.
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.33−0.35 (-0.21%)
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences RSU rollforward — Shares vested (M shares) by Year
Gilead Sciences RSU rollforward — Shares vested (M shares): 11 in FY2025, down 4.5% from a year earlier.
Latest, FY2025
11
Period ended Dec 31, 2025
Change on a year earlier
-4.5%
11 in FY2024
History
9 years
Since FY2014
Sources
9
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-24) ↗
Reported in Form 10-K Note 13.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | RSU rollforward — Shares vested (M shares) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11 | -4.5% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 11 | +2.8% | Form 10-K (filed 2025-02-28) ↗ |
| FY2023 | Dec 31, 2023 | 11 | +20.2% | Form 10-K (filed 2024-02-23) ↗ |
| FY2022 | Dec 31, 2022 | 9 | +27.1% | Form 10-K (filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 7 | +9.4% | Form 10-K (filed 2022-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 6 | +20.8% | Form 10-K (filed 2021-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 5 | -5.7% | Form 10-K (filed 2020-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 6 | – | Form 10-K (filed 2019-02-26) ↗ |
| FY2014 | Dec 31, 2014 | 6 | – | Form 10-K (filed 2015-02-25) ↗ |
Cite this data
StockData. (2026). Gilead Sciences RSU rollforward — Shares vested (M shares), annual FY2014–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/rsu-vested-sh
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.